Effects of Halofantrine Hydrochloride (Halfan) on the Histology of the Ovary of Mature Female Wistar Rats

JO Adjene and FO Agoreyo

Abstract

Halofantrine hydrochloride (halfan) was administered via oral route to matured female wistar rats weighing 180–200g.  The Wistar rats were randomly selected and divided into six groups of four rats each, making a total of twenty four rats and coded A1, A2, A3, B1, B2 and B3. Groups A3 and B3 were used as controls. Three consecutive doses of 1mg/100g halfan each were administered to group A1 at six hourly intervals while three doses of 2mg/100g halfan each were administered to group A2 at six hourly intervals.  The animals were sacrificed on the 5th day after drug administration by cervical dislocation. Animals in groups B1 and B2 were given doses corresponding to A1 and A2 respectively, but in addition drug administration was repeated the fifth day following the day of first administration. The animals in this group were sacrificed on the tenth day by cervical dislocation, the ovaries were removed, blotted dry, fixed in 10% formal saline for histological processing and studies. Histological changes observed in the ovary include retarded growth of follicles, reduction in size and number of follicles, increase in cytoplasmic vacuolation, constriction of blood vessels, absence of corpora lutae and cases of cellular necrosis. These alterations were more pronounced in those groups sacrificed on the tenth day. (Afr J Reprod Health 2003; 7[1]: 113–120)

 

Keywords: Halofantrine hydrochloride, ovarian follicles, Wistar rats

Full Text:

XML

References

Donham RS, Ogilvie KM, Kerner TM and Stetson MH. Daily Rhythms of Hew, 1990.

Epey LL. Ovulation as an inflammatory reaction. A hypothesis. BiolReprod 1980; 22: 73.

Geshickter CF and Byrnes EW. Factors influencing the development and time of appearance of mammary cancer in response to oestrogen in rat. Arch Path 1942; 33: 334–56.

Heywood R and Wadsmorth PF. The experimental toxicity of estrogen. J Inter EncyclopPharmacolTher 1980.

Horton RJ. Halofantrine in the treatment of multi-drug resistant malaria. Preclinical trials on halofantrine: halofantrine handbook, 1984, 11.

Howells RC. Advances in chemotherapy. Br Med Bull 1982; 193–199.

Loizeaux PS and Grenan MM. Research report WARAIR IND., No. 9847, Suppl. 5, 1977.

Oduola AM, Salako LA, Millons WK, Walker O and Desjardins RE. Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparium. Lancet 1987; ii: 1304–1305.

Singh S and Paduanadhan R. Effect of chlorpromazine (CP2) on developing rat brain. A morphological and histological study. Cong Anom 1978; 18: 251–259.

Smithkline and French. Production Data Manual, 1988.

Westerholm B. Clinical toxicology of estrogens. J Inter EncylPharmacolTher 1980; 10(2): 337–49.

Wilson A, Schild HO and Modell W. Applied Pharmacology. 11th edition. Longman Group Ltd., 1975, 255–7.

WHO. J Chemother Mal Sci Rep 1984.

Yoshimura Y, Dharmarajan AM, Gips S, Adachi T, Hosoi Y, Atlas SJ and Wallach EE. Effects of Prostacyclin on ovulation and microvasculation of the in vitro perfused rabbit ovary. Am J ObstetGynecol 1988; 15(4): 977–82.

Mbori-Ngacha DA, Onyango FE, Chunge C, et al. Efficacy of halofantrine in the treatment of uncomplicated falciparum malaria. East Afr Med J 1995; 72(12): 976–9.

Monlun E, Le Matayer P, Szwandt S, et al. Cardiac complication of halofantrine: a prospective study of 20 patients. Trans R Sco Trop Med Hyg 1995; 89: 430–3.

Matson PA, Luby SP, Redd SC, et al. Cardiac effects of standard dose halofantrine therapy. Am J Trop Med Hyg 1996; 54(3): 229–31.

Agoreyo FO and Adjene JO. Histological study of the effect of halofantrine hydrochloride on the histology of uterine tube of mature female wistar rats. J Med Biomed Res 2002; 1(1): 27–31.

Refbacks

  • There are currently no refbacks.